Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,567 | 24,351 | 39,916 | 65,813 | 21,688 |
| Marketable Securities | 14,236 | 23,198 | 28,447 | 28,300 | 63,117 |
| Receivables | 979 | 840 | 1,310 | 1,199 | 1,863 |
| TOTAL | $55,180 | $52,697 | $71,895 | $97,830 | $91,285 |
| Non-Current Assets | |||||
| PPE Net | 2,740 | 3,089 | 3,348 | 3,660 | 4,092 |
| Investments And Advances | 2,496 | 3,085 | 2,309 | 1,614 | 2,644 |
| Other Non-Current Assets | 8,969 | 9,369 | 9,721 | 10,094 | 9,039 |
| TOTAL | $14,205 | $15,543 | $15,378 | $15,367 | $15,775 |
| Total Assets | $69,386 | $68,241 | $87,273 | $113,197 | $107,060 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,703 | 16,120 | 13,389 | 17,551 | 16,578 |
| Accrued Expenses | 956 | 1,511 | 1,819 | 2,022 | 4,497 |
| Other current liabilities | 50,384 | 11,420 | 9,542 | 13,255 | N/A |
| TOTAL | $69,824 | $31,708 | $27,327 | $35,326 | $23,499 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 42 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 7,282 | 8,002 | 8,695 | 9,368 | 10,020 |
| TOTAL | $7,282 | $8,002 | $8,695 | $9,368 | $10,020 |
| Total Liabilities | $77,106 | $39,710 | $36,022 | $44,693 | $33,519 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,572 | 53,143 | 36,674 | 36,667 | 26,100 |
| Common Shares | 54 | 37 | 37 | 36 | 26 |
| Retained earnings | -1,818,930 | -1,773,433 | -1,749,914 | -1,730,219 | -1,710,838 |
| Other shareholders' equity | -648 | -662 | -661 | -676 | -623 |
| TOTAL | $-7,720 | $28,531 | $51,251 | $68,504 | $73,540 |
| Total Liabilities And Equity | $69,386 | $68,241 | $87,273 | $113,197 | $107,060 |